ALKS

Alkermes plc

Healthcare›Biotechnology|NASDAQ Global Select|IE

Price

$34.84

Market Cap

$5.81B

Beta

0.39

P/E

23.9

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)-5.25%

EPS Growth (YoY)-34.10%

Revenue CAGR 3Y+9.90%

P/E Ratio23.9

PEG Ratio—

FCF Yield+8.27%

Debt / Equity0.04

Interest Coverage20.7x

No credit card required

Already have an account? Sign in to view the full analysis for ALKS.